Aquablation uses a robotically-guided, ultrasound-mapped high-pressure waterjet to remove obstructing prostate tissue without heat. It is NICE-approved in the UK, produces symptom improvements comparable to TURP, and has a significantly lower rate of retrograde ejaculation — making it particularly suited to sexually active men with benign prostate enlargement.
Benign prostate enlargement (BPH) is one of the most common conditions affecting men over 50 — and the range of surgical treatments has expanded considerably. Aquablation is among the newer options, approved by NICE in 2020 and now available at selected centres across the UK, including London. For the right patient, it offers a compelling combination: symptom improvement comparable to the traditional gold standard, with a significantly lower risk of affecting ejaculation.
What is Aquablation?
Aquablation uses the AQUABEAM Robotic System — a combination of real-time ultrasound imaging and a robotically-controlled high-pressure waterjet — to remove obstructing prostate tissue. Unlike TURP, which uses an electrified loop and generates heat, the waterjet is inherently cool. The absence of thermal energy is the key difference: heat is responsible for much of the nerve damage that causes retrograde ejaculation in conventional surgery.
The procedure is performed under general or spinal anaesthesia. Before the waterjet is activated, the urologist maps the prostate in detail using ultrasound, defining precisely which tissue should be removed and which structures to protect. The robotic arm then executes the planned resection automatically, guided by that map.
Aquablation received NICE approval in the UK in 2020 (technology appraisal TA593). The WATER and WATER II clinical trials demonstrated symptom improvement equivalent to TURP, with retrograde ejaculation rates of approximately 10% versus 65–90% for TURP.
How is it different from TURP?
TURP — transurethral resection of the prostate — uses an electrically heated loop to cut and remove tissue. It is highly effective and has decades of outcome data behind it. The trade-off is that the heat used inevitably damages the ejaculatory ducts and nearby nerves, resulting in retrograde ejaculation (dry orgasm) in the majority of men.
Aquablation removes tissue mechanically rather than thermally. Because no heat is involved, the nerves controlling ejaculation are far less likely to be damaged. This does not mean there is zero risk — but the difference in published rates is substantial.
- Aquablation retrograde ejaculation rate: approximately 10% (WATER trial)
- TURP retrograde ejaculation rate: approximately 65–90%
- Symptom improvement (IPSS score reduction): broadly equivalent between the two
- Aquablation works across a wider range of prostate sizes — up to approximately 150cc
- The robotic guidance removes operator-to-operator variability in resection depth
Who is Aquablation suited to?
Aquablation tends to be discussed with men who meet most of the following:
- Diagnosed BPH causing bothersome urinary symptoms not controlled by medication
- Sexually active and wishing to preserve ejaculatory function
- Prostate volume between 30 and 150cc
- Fit for general or spinal anaesthesia
- No previous pelvic radiotherapy or major bladder neck surgery
It is not automatically the right choice for every man with BPH. Men with very small prostates, those who have already experienced retrograde ejaculation, or those for whom a shorter procedure under local anaesthetic is preferable may be better served by Rezūm, UroLift or other options.
What happens on the day?
The procedure is carried out in an operating theatre under general or spinal anaesthesia and takes approximately 30–60 minutes, depending on prostate size. Key steps are:
- A transrectal ultrasound probe is used to image the prostate in real time
- The surgeon maps the prostate on screen, defining the treatment zone and marking structures to protect
- The AQUABEAM system delivers a precisely controlled waterjet that removes the mapped tissue
- A catheter is placed at the end of the procedure to allow the urethra to heal
Most men stay in hospital for one to two nights. The catheter is typically removed within 24–48 hours, compared with several days for TURP — this is one reason recovery after Aquablation tends to feel more comfortable in the immediate period.
Recovery — what to expect
Recovery is broadly similar to other endoscopic BPH procedures. Most men notice improved urinary flow within the first few weeks, though temporary urgency, frequency and occasional bleeding in the urine can occur during the healing phase.
- Days 1–2: catheter in situ, light activity only, some urinary burning normal
- Week 1–2: catheter removed, urinary frequency and urgency common as tissue heals
- Weeks 3–6: urinary symptoms typically settle; most men see clear improvement
- 3 months: most men have reached their best functional outcome
- Return to driving: usually 1–2 weeks; return to work (desk-based) 1–2 weeks
- Strenuous exercise and sexual activity: typically 4–6 weeks
Is Aquablation available on the NHS?
NICE approved Aquablation in 2020 (TA593), but NHS availability in the UK remains limited to centres that have invested in the AQUABEAM system. Access varies significantly by trust. Privately, it is available at a smaller number of specialist units. If you are considering Aquablation, it is worth asking specifically whether your consultant is trained in and has direct access to the system — not all urologists offering BPH treatment have this.
Questions worth asking at your consultation
- What is my prostate volume and does it fall within the Aquablation range?
- Am I a suitable candidate based on my anatomy and bladder function?
- What is your personal experience with Aquablation — how many have you performed?
- How does my risk of retrograde ejaculation compare between Aquablation and TURP for my specific case?
- Are there reasons TURP, HoLEP or Rezūm might be more appropriate for me?
- What is the re-treatment rate and what would happen if symptoms returned?
Frequently asked questions
The procedure itself is done under general or spinal anaesthesia, so there is no pain during surgery. Afterwards, most men experience some burning or discomfort when passing urine for a week or two, and urinary urgency is common during the healing phase. This is similar to other BPH procedures and typically settles within a few weeks.
Erectile function is largely preserved after Aquablation. The main sexual side effect is retrograde ejaculation (dry orgasm), which occurs in approximately 10% of cases — significantly less than TURP. Erectile dysfunction is an uncommon complication of any BPH surgery and is not specific to Aquablation.
Medium-term follow-up data (3–5 years) shows durable symptom improvement comparable to TURP. Longer-term data is still being collected as the procedure is relatively new. As with all BPH treatments, some men may require retreatment over time as the prostate continues to grow.
Yes — one of Aquablation's advantages over TURP is that it is effective across a wider range of prostate sizes, up to approximately 150cc. The WATER II trial specifically studied prostates between 80 and 150cc and demonstrated good outcomes. Your suitability will be confirmed at consultation based on your specific anatomy.
They address different patient profiles. Rezūm (water vapour/steam therapy) is typically suited to men with smaller prostates and can be done under local anaesthetic, but durability data beyond 5 years is more limited. Aquablation suits a broader size range and carries strong medium-term durability data. Neither is universally "better" — the right choice depends on your anatomy, priorities and general health.
Ask about Aquablation at your consultation
Mr Torath Ameen offers assessment and treatment for benign prostate enlargement at his London clinics. If you would like to discuss whether Aquablation is appropriate for you, book a consultation.
This article is intended for general patient education only. It does not constitute medical advice and may not apply to every individual's circumstances. Clinical decisions should always be made in consultation with a qualified healthcare professional. If you are concerned about your health, please seek prompt medical assessment.